Carlos Plaza

Stromal disrupting effects of nab-paclitaxel in pancreatic cancer

Rafael Álvarez, Mónica Musteanu, Elena García-García et al. · British Journal of Cancer · 2013 · 291 citations · Full text

Medicine, Oncology, Surgery +17

SPARC Expression Did Not Predict Efficacy of <i>nab</i> -Paclitaxel plus Gemcitabine or Gemcitabine Alone for Metastatic Pancreatic Cancer in an Exploratory Analysis of the Phase III MPACT Trial

Manuel Hidalgo, Carlos Plaza, Mónica Musteanu et al. · Clinical Cancer Research · 2015 · 131 citations · Full text

Medicine, Oncology, Pharmacology +12

A Comparison of EGFR Mutation Testing Methods in Lung Carcinoma: Direct Sequencing, Real-time PCR and Immunohistochemistry

Bárbara Angulo, Esther Conde, Ana Suárez‐Gauthier et al. · PLoS ONE · 2012 · 107 citations · Full text

Medicine, Genetics, Oncology +17

A comparative study of neoadjuvant treatment with gemcitabine plus nab-paclitaxel versus surgery first for pancreatic adenocarcinoma

Benedetto Ielpo, Riccardo Caruso, Hipólito Durán et al. · Surgical Oncology · 2017 · 74 citations

Medicine, Oncology, Surgery +15

Preoperative treatment with gemcitabine plus nab-paclitaxel is a safe and effective chemotherapy for pancreatic adenocarcinoma

Benedetto Ielpo, H. Durán, Eduardo M. Diaz et al. · European Journal of Surgical Oncology · 2016 · 71 citations

Medicine, Oncology, Surgery +11